Literature DB >> 30212364

Is PASH Syndrome a Biofilm Disease?: A Case Series and Review of the Literature.

Joey Karim Ead1, Robert J Snyder1, Jaime Wise2, Cherison Cuffy1, Hamed Jafary1, Karen Fischborn1.   

Abstract

INTRODUCTION: When occurring together, pyoderma gangrenosum, severe acne, and hidradenitis suppurativa have been described as PASH syndrome. Due to the chronic autoinflammatory state existing in affected patients, PASH syndrome has been attributed to the dysregulation of wound healing. CASE REPORTS: Two cases are presented that demonstrate the paradigmatic clinical features of PASH syndrome and its potential link as an expanding spectrum of bacterial biofilm disorder.
CONCLUSIONS: As reported herein, based on biofilm's clinical presentation and resistance to proper wound healing, it could serve as the common denominator and may redirect clinicians' treatment pathways in the near future.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30212364

Source DB:  PubMed          Journal:  Wounds        ISSN: 1044-7946            Impact factor:   1.546


  4 in total

1.  [Painful ulceration, abscesses and scars in a 39-year-old woman].

Authors:  Conrad Hempel; Julia Zarnowski; Jan-Christoph Simon; Regina Treudler
Journal:  Hautarzt       Date:  2021-01       Impact factor: 0.751

2.  Wound care, adalimumab, and multidisciplinary approach in a patient affected by PASH syndrome.

Authors:  Orlando Zagaria; Angelo Ruggiero; Gabriella Fabbrocini; Lucia Gallo; Marco Romanelli; Claudio Marasca
Journal:  Int Wound J       Date:  2020-05-22       Impact factor: 3.315

3.  Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome: A Case Report and Literature Review.

Authors:  Jundong Huang; Lemuel Shui-Lun Tsang; Wei Shi; Ji Li
Journal:  Front Med (Lausanne)       Date:  2022-03-24

4.  Recalcitrant Ulcerative Pyoderma Gangrenosum of the Leg Responsive to Tildrakizumab: A Case Report.

Authors:  Liang Joo Leow; Nicolas Zubrzycki
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-08-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.